FridayJan 21, 2022 11:51 am

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Poised as First Prototype of Green Ammonia System Readies for Deployment

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is readying the first prototype of its proprietary green ammonia (“NH3”) system for deployment in the summer of 2022. This comes as green NH3 gains attention as a solution to CO2 emission problems associated with fossil-fuel-dependent industries such as aviation. FuelPositive’s system produces green ammonia from sustainable electricity, water and air at a fraction of the cost of delivering traditionally produced (“grey”) NH3. It also requires less energy to produce green NH3 on-site, as needed. “In August 2020, a consortium made up of the United Kingdom’s Science and Technology Facilities Council (‘STFC’) and Reaction Engines…

Continue Reading

FridayJan 21, 2022 11:40 am

QualityStocksNewsBreaks – Nowigence Inc.’s Pluaris(TM) Platform Enabling Users as AI Gains Steam

Nowigence, a fast-growing software-as-a-service (“SaaS”) company that has developed an innovative, ready-to-use artificial intelligence (“AI”) platform called Pluaris(TM), is establishing a stronghold in the burgeoning AI space. Accelerated by the global pandemic, the adoption of AI is gaining steam, with 2022 projected to be a year when AI becomes a mainstream technology. “Nowigence’s Pluaris is a cloud-based app created for just this time and place, enabling users to read more in less time. The innovative platform allows individuals, teams and enterprises to quickly evaluate and analyze knowledge from massive amounts of public and private textual data,” reads a recent article.…

Continue Reading

FridayJan 21, 2022 10:55 am

QualityStocksNewsBreaks – DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF) Featured in Broadcast Discussing Successful Close of SEBA Bank Funding

DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF), a digital asset investment firm bridging the gap between traditional capital markets and decentralized finance, is featured in a NetworkNewsAudio (“NNA”) release. The audio press release covers the recent closing of a CHF110 million Series C funding round into SEBA Bank; the bank is a fully integrated, FINMA-licensed digital assets banking platform. According to the release, the funding was co-led by DeFi Technologies, which made an investment of CHF25 million. As a result of that investment, DeFi Technologies will be allotted a seat on SEBA Bank's board of directors. Other funding…

Continue Reading

ThursdayJan 20, 2022 1:03 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Featured in EDGE Podcast Interview

Lexaria Bioscience (NASDAQ: LEXX) CEO and chair Chris Bunka is the guest on a recent episode of the EDGE podcast. Hosted by entrepreneur and angel investor Brandon C. White, the EDGE is a podcast series focused on providing a playbook for business owners that takes a look at the inner game of building a successful business and giving listeners the edge to become smarter, healthier and richer. Lexaria Bioscience is a global innovator in drug-delivery platforms. During the interview, Bunka shared his background and the journey that led him to Lexaria. He also talked about Lexaria’s business model and the…

Continue Reading

ThursdayJan 20, 2022 12:12 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at Virtual Investor 2022 Top Picks Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today announced that its CEO John Climaco will participate in the Virtual Investor 2022 Top Picks Conference at 11:00 a.m. ET on Wednesday, Jan. 26, 2022. As part of the virtual event, the company will provide a corporate presentation followed by an interactive Q&A session. In addition to the moderated portion, investors and attendees will have the opportunity to submit questions live during the event or in advance of the conference via www.VirtualInvestorCo.com.…

Continue Reading

ThursdayJan 20, 2022 11:29 am

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Launches New YouTube Series – ‘Medically Speaking’

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced the launch of its new YouTube series entitled “Medically Speaking,” designed to enhance plant-based education and equip consumers with the necessary knowledge to achieve their plant-based goals. The new series will center around informative conversations with the PlantX medical advisory board on plant-based topics. Beyond providing evidence-based information to clarify potential questions and knowledge gaps in the plant-based space, Medically Speaking also aims to offer creative solutions to overcoming plant-based challenges as approved and discussed by trusted health care professionals. “We have seen a tremendous global shift to plant-based diets…

Continue Reading

ThursdayJan 20, 2022 10:51 am

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) Welcomes Four New Operators, on Track for Record 2022

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) is a propriety software-as-a-service (“SaaS”) technology company delivering mobile live dealer technology (VegasLounge(TM)) to online gaming operators globally. The company announced that it has gone live with four new operators, now offering Playgon's Live Dealer games to global clients. This brings Playgon to a total of 30 operators utilizing the company's technology, with an additional five operators in the queue at various stages of onboard testing. “We are very pleased to welcome four new operators into the Playgon family. They are impressed with our technology and are already contributing to player activity…

Continue Reading

WednesdayJan 19, 2022 2:04 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Innovations and Advancements in the CBD Market Webinar

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and services to the worldwide food and beverage, biotherapeutics and personal wellness industries, among others, today announced its participation in the Jan. 20, 2022, Innovations and Advancements in the CBD Market webinar. The real-time, interactive “fireside chat,” sponsored by FORCE Family Office, will feature three companies that have released or are about to release important, innovative products and services and/or advancements in the CBD space. Pressure BioSciences, which is planning for a mid-2022 release of its revolutionary Ultra Shear Technology(TM) (“UST”(TM))…

Continue Reading

WednesdayJan 19, 2022 1:19 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Standing Distinct by Creating Sophisticated, Luxurious Crossover EV-SUV

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, aims to set itself apart from the rest of the automotive pack through the creation of a sophisticated and luxurious crossover EV-SUV, a vehicle that has been meticulously designed by the creators of the famed Rolls Royce Ghost, all while boasting Tesla-rivaling performance. Mullen Automotive debuted its Mullen FIVE EV Crossover at the recent LA Auto Show, where it received the show’s ZEVA(R) Award for top all-electric SUV, beating out entries from the likes of Lincoln and Rivian. “The Mullen FIVE, starting at $55,000, is set to come equipped with…

Continue Reading

WednesdayJan 19, 2022 1:02 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Strengthening ‘Emerging Best-in-Class Position’ in Evolving Industry

Cybin (NYSE American: CYBN) (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently received a notice of allowance from the U.S. Patent and Trademark Office (“USPTO”). The notice was regarding Cybin’s patent application connected to its investigational deuterated psychedelic tryptamine compound, CYB004, for the potential treatment of anxiety disorders. “The receipt of this notice of allowance from the USPTO represents an important milestone in expanding our intellectual property portfolio progressing psychedelics to therapeutics for the countless patients in need, and strongly demonstrates the company’s dedication to the discovery and development of differentiated psychedelic-based…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered